Does UPADACITINIB Cause Superinfection bacterial? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Superinfection bacterial have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.
13
Reports of Superinfection bacterial with UPADACITINIB
0.0%
of all UPADACITINIB reports
1
Deaths
10
Hospitalizations
How Dangerous Is Superinfection bacterial From UPADACITINIB?
Of the 13 reports, 1 (7.7%) resulted in death, 10 (76.9%) required hospitalization, and 7 (53.8%) were considered life-threatening.
Is Superinfection bacterial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Superinfection bacterial?
TACROLIMUS (78)
MYCOPHENOLATE MOFETIL (76)
RITUXIMAB (72)
PREDNISONE (70)
PREDNISOLONE (52)
CYCLOPHOSPHAMIDE (38)
METHYLPREDNISOLONE (35)
METHOTREXATE (31)
CYCLOSPORINE (29)
DEXAMETHASONE (26)
Which UPADACITINIB Alternatives Have Lower Superinfection bacterial Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL